Article
Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
Acta neuropathologica - 1 Jun 2015
Collins V Peter, Jones David T W, Giannini Caterina
Abstract excerpt
Pilocytic astrocytomas (PAs) were recognized as a discrete clinical entity over 70 years ago. They are relatively benign (WHO grade I) and have, as a group, a 10-year survival of over 90%. Many require merely surgical removal and only very infrequently do they progress to more malignant gliomas. While most show classical morphology, they may present a spectrum of morphological patterns, and there are difficult...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.